Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price
28 January 2026
1 min read

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

New York, January 28, 2026, 13:10 EST — Regular session.

Avnet, Inc. shares surged roughly 11% Wednesday following a quarterly earnings report that beat estimates and a third-quarter forecast that exceeded expectations. By 1:01 p.m. EST, the stock had climbed 11.3% to $58.65, reaching an intraday peak of $58.84 earlier.

This move is crucial as investors seek clear signals on demand and pricing within the global electronics supply chain, where distributors often risk carrying excess inventory if customers halt orders.

Avnet serves as a key indicator for this segment of tech hardware. Positioned between chipmakers and end customers, shifts in its bookings and inventory management tend to appear early—often ahead of any comments from the manufacturers themselves.

Avnet reported fiscal second-quarter sales of $6.319 billion in a filing with the U.S. SEC, with adjusted diluted EPS of $1.05 and GAAP diluted EPS at $0.75 for the quarter ending Dec. 27, 2025. The company projected fiscal third-quarter sales between $6.20 billion and $6.50 billion, and adjusted EPS ranging from $1.20 to $1.30. The midpoint suggests about 1% sequential sales growth, despite a seasonal slowdown in Asia tied to Lunar New Year.

Analysts were looking for earnings of $0.95 per share this quarter, according to RTTNews. Adjusted EPS, however, increased 20.7% from $0.87 a year ago. Operating income dropped 5.9% year-over-year to $146.2 million, even though sales rose 11.6%, RTTNews said. 1

Chief Executive Phil Gallagher reported that the company delivered operating cash flow, cut days of inventory, and observed trends he called “encouraging.” He also noted Avnet’s third-quarter outlook anticipates “above-trend seasonal growth and improving margins.” 2

Avnet’s rise boosted some stocks in the distribution sector. Arrow Electronics jumped roughly 4.7%, while TD SYNNEX gained around 1.1% by midday.

During the earnings call, Avnet leaders sounded optimistic about the year ahead. CFO Ken Jacobson noted that “2026 should provide several opportunities” for the company to assist customers and suppliers as market conditions evolve. 3

“Adjusted” results exclude specific items that might distort reported profit, offering investors a clearer view of core performance. Another key figure is “days of inventory,” which estimates how long products remain unsold; a decline here can relieve cash flow and margin strains for distributors.

The business still operates on razor-thin margins, so even slight shifts in demand or pricing can quickly erode profits. If customers pull back on orders or discounting creeps back in, maintaining the outlook will be tough, despite any revenue gains.

Avnet’s upcoming challenge: hitting its fiscal third-quarter targets for the period ending March 28. Traders are zeroing in on how well the company manages inventory and advances its margins throughout the quarter.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Bloom Energy stock jumps as China Renaissance starts coverage; targets hit $207
Previous Story

Bloom Energy stock jumps as China Renaissance starts coverage; targets hit $207

Why Intuitive Machines (LUNR) stock is up today: NASA Artemis II tracking role, fresh $26 target
Next Story

Why Intuitive Machines (LUNR) stock is up today: NASA Artemis II tracking role, fresh $26 target

Go toTop